Robotic knee replacement: what patients noticed a year later

Robotic knee replacement: what patients noticed a year later

A person considering total knee replacement may want to know how often they will notice the artificial joint while walking, climbing stairs or getting out of a chair. The UK RACER-Knee trial made joint awareness its main measure of success. A second trial, RASKAL, examined whether robotics offered an advantage over computer navigation and tracked patients for two years. [1][2]

Mako compared with conventional instruments

Across ten British hospitals, 33 surgeons participated in RACER-Knee. Investigators randomly assigned 339 people with advanced knee osteoarthritis to replacement using the Mako robotic arm or conventional instruments. Patients and outcome assessors were masked to the allocation. At 12 months, mean Forgotten Joint Scores were 49.2 with Mako and 50.2 with conventional surgery. The adjusted difference was −1.5 points, with a 95% confidence interval from −7.5 to 4.5. [1]

The investigators had set a 12-point improvement as their target. Even the upper end of the confidence interval fell below that target. Robotic surgery was more costly in this trial. Its cost findings reflect the participating UK services. [1]

A different comparator and a longer view

RASKAL enrolled 303 patients and compared robotic assistance with computer-assisted surgery. A separate random allocation tested functional versus mechanical alignment. At two years, the technology comparison showed no significant advantage in the principal patient-reported knee score. The trial also found similar patient satisfaction across technology groups. The comparator matters to a hospital that already uses computer navigation. [2]

The decision beyond the first two years

For primary replacement, the evidence supports discussing expected symptoms and function using the actual platform and comparator. RACER-Knee excluded people needing complex implants. Its one-year result cannot establish long-term implant survival or predict outcomes in revision surgery. A purchasing team can separately track per-case cost, theatre time and patient-reported recovery against its current practice. [1][2]

What to take into practice

The two trials found no meaningful patient-reported advantage for the robotic approaches they tested at their respective endpoints. Implant longevity remains a longer-term question. [1][2]

Browse the MedBay catalogue for Orthopedic surgery

Sources

Evidence checked on 21 November 2026.

[1] RACER-Knee pragmatic randomised trial, The Lancet (2026-08-20).

[2] MacDessi et al., RASKAL randomised trial, The Bone & Joint Journal (2026-04-07).

Leave a Reply

Your email address will not be published. Required fields are makes.

Select your currency
USD United States (US) dollar